Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Astellas Pharma Inc. (ALPMY) had Cash Flow from Investing Activities of $-570.60M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$7.95B |
|
$2.20B |
|
$14.83B |
|
$22.78B |
|
$7.61B |
|
$3.86B |
|
$5.31B |
|
$12.92B |
|
$9.86B |
|
$-992.18M |
|
$9.86B |
|
-- |
|
| Cash Flow Statement Financials | |
$616.68M |
|
|
Cash Flow from Investing Activities |
$-570.60M |
$-1.13B |
|
$2.22B |
|
$1.19B |
|
$-1.03B |
|
-- |
|
$-851.35M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|